India’s largest integrated power company, Tata power announced on Friday that its wholly-owned subsidiary, Tata Power Renewable Energy Limited (TPREL) received a letter of award (LoA) to develop a solar project in Maharashtra with a capacity of 100 MW by Maharashtra State Electricity Distribution Co. Ltd (MSEDCL).

The shares of Future Retail locked in at upper circuit of 5 per cent on Friday after market reports suggested that Future Group is considering to sell stakes in Future Retail and some other units to Mukesh Ambani’s Reliance Industries Limited (RIL).

Every retiree wishes to make the best possible use of the retirement corpus. Let us look at investment strategies that one can adopt in thier retirment phase.

The market opened in the green on June 19, 2020. The previous trading session witnessed the Sensex going up 700.13 points to end at 34,208.05 and the Nifty was up 210.50 points to close at 10,091.65 .

The market opened in the green on June 19, 2020. The previous trading session witnessed the Sensex going up 700.13 points to end at 34,208.05 and the Nifty was up 210.50 points to close at 10,091.65 .

The market opened in the green on June 19, 2020, overall volumes in futures & options currently stand at 6.54 crore contracts with a turnover of Rs. 33,83,661.45 crore.

The market opened in the green on June 19, 2020, overall volumes in futures & options currently stand at 6.54 crore contracts with a turnover of Rs. 33,83,661.45 crore.

The credit profile of Tata Motors was already under stress due to lower auto sales and falling demand in key markets even before Coronavirus outbreak.

Reliance Industries’ Jio Platforms has attracted huge amount of investments from some of the leading names of the business world globally. As a result, the stock of RIL has more than doubled the money of investors since the beginning of FY21.

Cipla Limited and Roche Products (India) Pvt Ltd have joined hands to provide better access and innovative medicines for patients in India. Through this partnership, Cipla will undertake the activities of marketing and distribution of Roche’s key trademark oncology drugs like Trastuzumab (Herclon), Bevacizumab (Avastin) and Rituximab (Ristova).